San Diego, CA, United States of America

Kathleen C Sappey

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathleen C Sappey. Retrieved from https://idiyas.com/inventor/kathleen-c-sappey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0


 

Average Co-Inventor Count = 12.9

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kathleen C. Sappey

Introduction

Kathleen C. Sappey is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of pharmaceutical sciences. With a total of eight patents to her name, she has made remarkable advancements in the development of compounds that target orexin receptors, which play a crucial role in regulating sleep and wakefulness.

Latest Patents

Among her latest patents are the disubstituted octahydropyrrolo[3,4-c]pyrroles, which are recognized as orexin receptor modulators. These compounds are particularly valuable in pharmaceutical compositions and methods aimed at treating various disorders associated with orexin activity, such as insomnia. The innovative nature of her work lies in the potential therapeutic applications of these compounds, which could significantly improve the quality of life for individuals suffering from sleep-related issues.

Career Highlights

Throughout her career, Kathleen has worked with notable companies, including Janssen Pharmaceutica, where she has contributed to groundbreaking research and development projects. Her expertise in the field has allowed her to play a pivotal role in advancing the understanding of orexin receptor modulation and its implications for treating sleep disorders.

Collaborations

Kathleen has collaborated with esteemed colleagues, including Wenying Chai and Michael Anthony Letavic, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Kathleen C. Sappey's innovative work in the realm of orexin receptor modulators exemplifies her dedication to improving healthcare through scientific advancements. Her contributions continue to pave the way for new treatments that address critical health issues related to sleep disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…